Title : Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.

Pub. Date : 2012 Nov

PMID : 23767198






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: The results of the current in vitro study corroborate the efficacy of the beta lactamase inhibitor tazobactam in improving the spectrum of activity and efficacy of cefoperazone. Cefoperazone beta-lactamase Klebsiella pneumoniae